Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $814.5000 (-1.05%) ($814.5000 - $814.5000) on Fri. Dec. 1, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.07% (three month average) | RSI | 63 | Latest Price | $814.5000(-1.05%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.4% a day on average for past five trading days. | Weekly Trend | REGN advances 0.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) SDY(52%) IBB(51%) SPLV(46%) XLV(46%) XLU(44%) | Factors Impacting REGN price | REGN will decline at least -0.535% in a week (0% probabilities). USO(-33%) ONLN(-33%) VXX(-29%) UNG(-28%) XLE(-24%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.535% (StdDev 1.07%) | Hourly BBV | -0.8 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $809(0.68%) | 10 Day Moving Average | $804.74(1.21%) | 20 Day Moving Average | $805.87(1.07%) | To recent high | -3.7% | To recent low | 5.1% | Market Cap | $86.36b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |